Blogs

March 16, 2026

टाइटन बायोटेक: ₹8 से ₹400 — 50 गुना मल्टीबैगर कहानी | वैल्यू इन्वेस्टिंग #Shorts

टाइटन बायोटेक: 50 गुना रिटर्न! मल्टीबैगर कहानी (हिंदी) जानिए कैसे टाइटन बायोटेक ने शुरुआती निवेशकों को 50 गुना रिटर्न दिया! YouTube Shorts: यहाँ देखें अस्वीकरण: यह […]
March 16, 2026

Titan Biotech: From ₹8 to ₹400 — The 50x Multibagger Story | Value Investing #Shorts

Titan Biotech (BSE: 524717) turned ₹8 into ₹400 — a stunning 50x multibagger return! Learn the 3 key factors that drove this incredible growth through value […]
March 16, 2026

Rupee at ₹93/$ — Why This Is a Golden Opportunity for Pharma & Biotech Investors

The Indian Rupee has depreciated to ~93 per US Dollar. While headlines scream doom, smart investors see this as a powerful tailwind for India's $30B+ pharma export engine. India is the Pharmacy of the World — and a weaker rupee makes it even more competitive. Here's why pharma & biotech stocks are the biggest beneficiaries.
March 16, 2026

Economic Moats: How to Find Companies That Competitors Simply Cannot Destroy — Lessons from Titan Biotech

What Is an Economic Moat? In the world of value investing, few concepts are as powerful — or as misunderstood — as the economic moat. Coined […]
+91-8448836436